MedTrace Logo

Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry

NCT01439698 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2017-02-20

No results posted yet for this study

Summary

The objective of this protocol is to establish a multicenter registry to evaluate the impact of radiofrequency ablation in the management of patients with pancreatico-biliary disorders including malignancies.

Conditions

Interventions

DEVICE

Radio Frequency ablation Probe

Any probe that can conduct radiofrequency ablation within biliary ducts.

Sponsors & Collaborators

  • Weill Medical College of Cornell University

    lead OTHER

Principal Investigators

  • Michel Kahaleh, MD · Weill Medical College of Cornell University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2018-12-01
Completion
2018-12-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01439698 on ClinicalTrials.gov